Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Summers

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reviews|March 17, 2004
Inadvertent omission of reference and credit to RJ Albin, et al, and the initial identification of prostate-specific antigenJ B Summers, J Kaminski
Journal of Medicinal Chemistry|July 5, 1996
Modulators of leukotriene biosynthesis and receptor activationC D Brooks, J B Summers
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Platelet activating factor antagonistsJ B Summers, D H Albert
Agents and Actions. Supplements|January 14, 1998
Symposium new drugs for inflammatory, allergic and immunologic diseaseJ B Summers, R D Dyer
Brain Research|February 12, 1998
Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. IM Gattu, J R Pauly, K L Boss, et al.
European Journal of Pharmacology|December 3, 1991
Inhibition of leukotriene biosynthesis in the rat peritoneal cavityP R Young, R L Bell, C Lanni, et al.
Journal of Medicinal Chemistry|March 1, 1987
Hydroxamic acid inhibitors of 5-lipoxygenaseJ B Summers, H Mazdiyasni, J H Holms, et al.
Pulmonary Pharmacology|April 1, 1994
The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxisP E Malo, R L Bell, T K Shaughnessy, et al.
Shock (Augusta, Ga.)|April 1, 1996
Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonistK T Kruse-Elliott, D H Albert, J B Summers, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonistD H Albert, T J Magoc, H D Kleinert, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reviews|March 17, 2004
Inadvertent omission of reference and credit to RJ Albin, et al, and the initial identification of prostate-specific antigenJ B Summers, J Kaminski
Journal of Medicinal Chemistry|July 5, 1996
Modulators of leukotriene biosynthesis and receptor activationC D Brooks, J B Summers
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Platelet activating factor antagonistsJ B Summers, D H Albert
Agents and Actions. Supplements|January 14, 1998
Symposium new drugs for inflammatory, allergic and immunologic diseaseJ B Summers, R D Dyer
Brain Research|February 12, 1998
Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. IM Gattu, J R Pauly, K L Boss, et al.
European Journal of Pharmacology|December 3, 1991
Inhibition of leukotriene biosynthesis in the rat peritoneal cavityP R Young, R L Bell, C Lanni, et al.
Journal of Medicinal Chemistry|March 1, 1987
Hydroxamic acid inhibitors of 5-lipoxygenaseJ B Summers, H Mazdiyasni, J H Holms, et al.
Pulmonary Pharmacology|April 1, 1994
The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxisP E Malo, R L Bell, T K Shaughnessy, et al.
Shock (Augusta, Ga.)|April 1, 1996
Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonistK T Kruse-Elliott, D H Albert, J B Summers, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonistD H Albert, T J Magoc, H D Kleinert, et al.
Pageof 4